Multicenter prospective observational study of dupilumab‐induced ocular events in atopic dermatitis patients

Abstract

This study showed that most dupilumab-induced blepharoconjunctivitis cases are de novo. AD severity and conjunctivitis at baseline were not found to be associated risk factors in this study.